The traditional picture of cancer patients as weak individuals requiring maximum rest and
protection is beginning to dissolve. Too much focus on the medical side and one's own …

Background Minimal qualitative data exist on the experiences of cancer patients treated with
immune checkpoint inhibitors or costimulatory antibodies. Understanding the day to day …

Simple Summary Immune checkpoint inhibitors (ICIs) are drugs which treat cancer by
manipulating the immune system. Exercise also influences the immune system and helps to …

Simple Summary The human immune system is robustly equipped to keep unnatural cell
growth in check in the body to suppress cancer progression. However, the cells and …

Four studies recently reported in the New England Journal of Medicine highlight advances
in treatment with immune checkpoint blockade across the cancer care continuum. These …

To improve the efficacy of immune checkpoint inhibitors (ICIs) for cancer treatment, various
strategies, including combination therapies with repurposed drugs, are being explored …

Cancer survival rates are generally increasing in the United States. These trends have been
partially attributed to improvement in therapeutic strategies. Cancer immunotherapy is an …

Background Immune checkpoint inhibitors (ICI) have revolutionised treating advanced
cancers. ICI are administered intravenously every 2–6 weeks for up to 2 years, until cancer …

The approval of the immune checkpoint inhibitor ipilimumab for the treatment of advanced
melanoma in 2011 spearheaded the development of other anticancer therapies with …

Simple Summary Cancer treatments can cause adverse effects such as cancer-related
fatigue. Immune checkpoint inhibitors (ICIs) are a relatively new therapy for some cancers …